Search Results 1531-1540 of 21361 for anti-TNF drugs

1. Drug to prevent RSV in babies approved: What you need to know - Mayo Clinic News Network

   The FDA approved a drug to help protect infants from respiratory syncytial virus (RSV). Learn more about the RSV drug.

2. Spatial and Molecular Architecture of Tumor Environments Responsive to IO (immuno-oncology) Therapy - Mayo Clinic

   Recommendation by the treating provider to initiate therapy with a commercially available, FDA approved, anti-PD-1-based therapy or anti-PD-L1therapy; The ...

3. Fentanyl (Transdermal Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

4. A Study to Evaluate RVT-1401 for the Treatment of Patients with Active, Moderate-to-severe Graves' Ophthalmopathy - Mayo Clinic

   Documented evidence at Screening of detectable anti-TSHR-Ab. Participant does not require immediate surgical intervention and is not planning corrective ...

5. Mayo Clinic study suggests patients with lung cancer be screened for MET oncogene

   ... anti-PD1 immunotherapy to relieve PD-L1 mediated immune suppression, however this treatment also failed.” Dr. Lou and his colleagues then used cell line ...

6. Fluticasone And Salmeterol (Inhalation Route) Description and Brand Names - Mayo Clinic

   Inhaled salmeterol is a long-acting bronchodilator. Bronchodilators are medicines that are breathed in through the mouth to open up the bronchial tubes (air ...

7. A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Impaired Renal Function - Mayo Clinic

   ... treatment and have either normal or impaired renal functions. Belantamab mafodotin (GSK2857916) is an antibody-drug conjugate (ADC) containing humanized anti ...

8. A Study of CDX-1127 (Varlilumab) in Patients with Select Solid Tumor Types or Hematologic Cancers - Mayo Clinic

   About this study. This is a study of CDX-1127, a therapy that targets the immune system and may act to promote anti-cancer effects.

9. Thomas Caulfield, Ph.D. - Mayo Clinic Faculty Profiles

   D., has a research background in biochemistry, medicinal chemistry, biophysics, computational modeling and in silico drug studies. His long-term focus is on ...

10. Radiation Oncology - Department home - Mayo Clinic

    Radiation causes some cancer cells to die immediately after treatment, but most die or become incapacitated as a result of the radiation-induced damage to the ...